Medulloblastoma clinical trials at UCSD
1 research study open to eligible people
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma
open to eligible people ages 12 months to 39 years
The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility of performing real-time drug screening on tissue taken during surgery, and of having a specialized tumor board assign a treatment plan based on the results of this screening and genomic sequencing. The aim of this trial is to allow every child and young adult with medulloblastoma to receive the most effective and least toxic therapies currently available, and will pave the way for improved understanding and treatment of these tumors in the future.
San Diego, California and other locations
Last updated: